The benefits and harms of a therapy are best estimated by a randomized clinical trial (RCT).1 In RCTs, the treatment groups are expected to be similar in prognostic factors, and thus any observed differences in outcomes are likely attributable to the treatment.1 However, RCTs are not always possible for every important population or effect, nor are they adequately powered to detect rare adverse events.1